Cargando…

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	de A. Boleti, Ana Paula, Almeida, Jeeser Alves, Migliolo, Ludovico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067940/ https://www.ncbi.nlm.nih.gov/pubmed/33063727 http://dx.doi.org/10.4103/1673-5374.295329

Ejemplares similares

Adipose tissue, systematic inflammation, and neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2022)

Role of myelin sheath energy metabolism in neurodegenerative diseases
por: Ravera, Silvia, et al.
Publicado: (2015)

Targeting glial metabolism in neurodegenerative diseases: detail matters
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Glial interference: impact of type I interferon in neurodegenerative diseases
por: Roy, Ethan, et al.
Publicado: (2022)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Nucleoredoxin-like 2 metabolic signaling impairs its potential contribution to neurodegenerative diseases
por: Corsi, Mariangela, et al.
Publicado: (2022)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Impacts of increased α-synuclein on clathrin-mediated endocytosis at synapses: implications for neurodegenerative diseases
por: Medeiros, Audrey T., et al.
Publicado: (2018)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: new perspectives
por: Silveira, Gustavo de Bem, et al.
Publicado: (2021)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Beneficial effects of date palm fruits on neurodegenerative diseases
por: Essa, Musthafa Mohamed, et al.
Publicado: (2016)

Tubulin glutamylation: a skeleton key for neurodegenerative diseases
por: van der Laan, Siem, et al.
Publicado: (2019)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Can foods influence the onset and progress of neurodegenerative diseases?
por: Piemontese, Luca, et al.
Publicado: (2022)

Brain-derived neurotrophic factor in main neurodegenerative diseases
por: Camuso, Serena, et al.
Publicado: (2022)

Cell senescence, loss of splicing, and lipid metabolism in TDP-43-related neurodegenerative processes
por: Torres, Pascual, et al.
Publicado: (2023)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
por: Duan, Yanhui, et al.
Publicado: (2020)

Potential of kynurenine metabolites in drug development against neurodegenerative diseases
por: Kubicova, Lenka, et al.
Publicado: (2020)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

How does resveratrol influence the genesis of some neurodegenerative diseases?
por: Tellone, Ester, et al.
Publicado: (2016)

Paracrine factors for neurodegenerative disorders: special emphasis on Parkinson's disease
por: Di Santo, Stefano, et al.
Publicado: (2016)

A substrate scaffold for assessment of nerve regeneration and neurodegenerative diseases
por: Chen, Wei-Hsin, et al.
Publicado: (2015)

The emerging epigenetics of PARK7 and its implication in neurodegenerative disease
por: Vavougios, George D., et al.
Publicado: (2018)

Human endogenous retroviruses: ammunition for myeloid cells in neurodegenerative diseases?
por: Gruchot, Joel, et al.
Publicado: (2019)

hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible
por: Rivetti di Val Cervo, Pia, et al.
Publicado: (2021)

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases
por: Maneu, Victoria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v5kj7tq16km58vphbmo8fcotk9